Actionable news
All posts from Actionable news
Actionable news in NWBO: Northwest Biotherapeutics, Inc.,

Short of Cash, Northwest Bio Flirts With Insolvency

Is Northwest Biotherapeutics (NWBO) financially insolvent?

The cancer immunotherapy company's cash position has plunged to the point where it may no longer be capable of paying its operating expenses, according to the latest quarterly report filed with the Securities and Exchange Commission.

Northwest Bio did not respond to questions about its financial health Thursday.

As disclosed in its 10-Q for the second quarter, Northwest Bio exited June with $2.1 million in cash on hand. On July 4, right after the second quarter ended, the company raised another $3.3 million in a follow-on stock offering.

JUST UPDATED – TheStreet's Biotech Bible! Before you invest one single dime in any biotech stock you have got to KNOW WHAT YOU ARE BUYING! Get THE most comprehensive text covering the 186 biotech companies that have gone public since 2013! There’s nothing else like it for digging into this highly speculative group of stocks. Grab a FREE copy today!

The $5.4 million in cash on hand at the beginning of July would have barely covered...